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Gastrin-releasing peptide (GRP) is a spinal itch transmitter expressed by a small population of dorsal horn interneurons (GRP neurons).
The contribution of these neurons to spinal itch relay is still only incompletely understood, and their potential contribution to pain-
related behaviors remains controversial. Here, we have addressed this question in a series of experiments performed in GRP::cre and
GRP::eGFP transgenicmalemice.Wecombinedbehavioral testswithneuronal circuit tracing,morphology, chemogenetics, optogenetics,
and electrophysiology to obtain a more comprehensive picture. We found that GRP neurons form a rather homogeneous population of
central cell-like excitatory neurons located in lamina II of the superficial dorsal horn. Multicolor high-resolution confocal microscopy
and optogenetic experiments demonstrated that GRP neurons receive direct input fromMrgprA3-positive pruritoceptors. Anterograde
HSV-based neuronal tracing initiated from GRP neurons revealed ascending polysynaptic projections to distinct areas and nuclei in the
brainstem, midbrain, thalamus, and the somatosensory cortex. Spinally restricted ablation of GRP neurons reduced itch-related behav-
iors to different pruritogens, whereas their chemogenetic excitation elicited itch-like behaviors and facilitated responses to several
pruritogens. By contrast, responses to painful stimuli remained unaltered. These data confirm a critical role of dorsal horn GRP neurons
in spinal itch transmission but do not support a role in pain.
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Introduction
Acute itch, verymuch like pain, is a protective sense thatmakes us
aware of potentially harmful stimuli or events. Activation of pru-
ritoceptive sensory afferents (“itch fibers”) elicits the desire to
scratch aiming at the removal of irritant stimuli from the skin.
Similar to sensory neurons activated by painful stimuli, prurito-
ceptors have their cell bodies in the DRGs and trigeminal ganglia,
from where they send peripheral axons to the skin and central
axons to the spinal cord or brainstem. The termination areas of
the central axons lie in the superficial layers of the spinal dorsal
horn or in the brainstem, where they make excitatory synaptic
connections with local second-order neurons.
In the last decade, several key players (receptors and neurons)
of peripheral and spinal itch pathways have been identified. In the
periphery, members of the mas-related GPCR family have been
found to play important roles as receptors for pruritogens. Mrg-
prA3 (MrgprX1 in humans) underlies the pruritic actions of
chloroquine, whereas other members of the Mrgpr family (A1,
A4, and C11) respond to the pruritic peptides FMRF, NPFF, and
BAM 8–22 (Liu et al., 2009). MrgprA3-positive pruritoceptors
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Significance Statement
Dorsal horn gastrin-releasing peptide neurons serve a well-established function in the spinal transmission of pruritic (itch)
signals. A potential role in the transmission of nociceptive (pain) signals has remained controversial. Our results provide further
support for a critical role of dorsal horngastrin-releasingpeptideneurons in itch circuits, butwe failed to findevidence supporting
a role in pain.
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are activated by a variety of itch stimuli, including activators of
histaminergic and nonhistaminergic itch, and their ablation
strongly reduces itch responses (Han et al., 2013). Additional
subsets of peripheral pruritoceptors are characterized by the ex-
pression of brain-type natriuretic peptide (Nppb) (Usoskin et al.,
2015) or somatostatin (Huang et al., 2018).
At the spinal level, a critical role in itch has been found for the
receptor activated by the neuropeptide gastrin-releasing peptide,
the gastrin-releasing peptide (GRP) receptor (GRPR) (Y.G. Sun
and Chen, 2007). Mice lacking GRPR display reduced scratching
responses to chloroquine, compound 48/80, and activation of the
protease activated receptor 2 (PAR2). The respective neurons
that express the GRPR (GRPR neurons) are located in the super-
ficial layers of the dorsal horn (Y.G. Sun and Chen, 2007). Recent
work has shown that these neurons are local spinal interneurons
that excite spinoparabrachial projection neurons to relay prurito-
ceptive signals to supraspinal CNS areas (Mu et al., 2017). Ablation
of the GRPR neurons almost completely abolishes itch-related be-
haviors evoked by different pruritogens, including histamine, chlo-
roquine, and serotonin (Y.G. Sun et al., 2009).
The studies on mice lacking the GRP receptor (Y.G. Sun and
Chen, 2007) or the GRPR neurons (Y.G. Sun et al., 2009) suggest
a specific role not only of GRP but also of the GRP releasing
neurons in itch, consistent with a “labeled line” for itch that
extends from the periphery at least to the spinal cord. However, a
more recent study (S. Sun et al., 2017) that used selective activa-
tion and ablation of GRP-expressing neurons reported evidence
for an additional role of these neurons in the transmission of
low-intensity pain signals. Here, we have readdressed this ques-
tion and undertook an in-depth analysis of the integration of
GRP neurons in dorsal horn neuronal circuits and of their con-
tributions to itch and pain-related behaviors. Our new data are
consistent with a critical and rather specific role of these neurons
in the spinal processing of pruritoceptive signals.
Materials andMethods
Mice. Experiments were performed on 6- to 12-week-old male mice kept
at a 12:12 h light/dark cycle. Permissions have been obtained from the
Canton of Zurich (permissions 257/2014, 031/2016, 023/2016, and 063/
2016). For details on the genetically modifiedmice used in this study, see
Table 1.
Immunohistochemistry and image analysis. Mice were perfused tran-
scardially with 20 ml of ice-cold ACSF (125 NaCl, 2.5 KCl, 1.25
NaH2PO4, 25 NaHCO3, 1 MgCl2, 2 CaCl2, 20 glucose equilibrated with
95% O2/5% CO2) followed by 100 ml of 4% ice-cold PFA (in 0.1 M
sodium phosphate buffer, pH 7.4). Lumbar spinal cords and brains were
dissected and postfixed for 2 and 4 h, respectively, with 4% PFA on ice.
The postfixed tissue was briefly washed with 0.1 M sodium phosphate
buffer and then incubated for cryoprotection in 25% sucrose solution (in
0.1 M sodium phosphate buffer) overnight at 4°C. Tissue was embedded
in NEG50 frozen section medium (Richard-Allen Scientific) and stored
at80°C until use. Spinal tissue and DRG tissue were cut into 30 and 16
mcryosections, respectively, using Hyrax C60 cryostat (Carl Zeiss) and
mounted onto Superfrost Plus microscope slides (Thermo Fisher Scien-
tific). Brain tissue and spinal cord tissue used for the neurochemical
characterization of GRP-eGFP cells were cut into 40 m section with
Hyrax KS 34 microtome (Carl Zeiss) and transferred to PBS for immu-
nostaining on free-floating sections. Immunofluorescence staining was
performed using combinations of antibodies and fluorescent conjugates
listed in Table 1. Spinal cord and brain sections were incubated with
primary antibodies in PBS supplemented with 0.3% Triton X-100 and
10% normal donkey serum overnight at 4°C and with secondary anti-
bodies solution in PBS supplemented with 0.3% Triton X-100 for 1 h at
room temperature. Sections were washed 3 times for 5–10 min in PBS
after each antibody incubation. Images were taken using an LSM 710
confocal laser scanning microscope (Carl Zeiss) equipped with a 0.8
NA  20 Plan-apochromat objective and a 1.3 NA  40 EC Plan-
Neofluar oil-immersion objective. Maximum intensity projections were
created fromZ-stack images (3–15 optical sections, 0.7–1.5mstep size)
and processed using ImageJ software (National Institutes of Health).
Immunofluorescence images of brain sections and chromogenic ISH
images of spinal cord tissue were taken using an Axio Imager Z1 micro-
scope (Carl Zeiss) equipped with 0.3 NA 10 EC Plan-Neofluar and 0.8
Table 1. Resource table
Reagent Resource Identifier
Mice
GRP::cre Mutant Mouse Regional
Resource Centers
RRID:MMRRC_031182-UCD
GRP::eGFP Mutant Mouse Regional
Resource Centers
RRID:MMRRC_010444-UCD
MrgrpA3::cre Xinzhong Dong Han et al., 2013
ROSA26lsl-ChR2 The Jackson Laboratory RRID:IMSR_JAX:012569
ROSAlsl-iDTR The Jackson Laboratory RRID:IMSR_JAX:007900
ROSAlsl-tdTom The Jackson Laboratory RRID:IMSR_JAX:007914
ROSAlsl-TVA Dieter Saur Seidler B et al., 2008
Antibodies (dilution)
Chicken anti-GFP (1:1000) Thermo Fisher Scientific RRID:AB_2534023
Mouse anti-calbindin (1:5000) Swant RRID:AB_10000347
Goat anti- Pax2 (1:200) R & D Systems RRID:AB_10889828
Goat anti-CGRP (1:500) Abcam RRID:AB_725807
Goat anti-tdTomato (1:1000) SICGEN RRID:AB_2722750
Guinea pig anti-Lmx1b (1:10,000) Carmen Birchmeier Muller et al. 2002
Guinea pig anti-VGluT2 (1:10,000) Millipore RRID:AB_2665454
Rabbit anti-GFP (1:1000) Molecular Probes RRID:AB_221570
Rabbit anti-NeuN (1:3000) Abcam RRID:AB_10711153
Rabbit anti-PKC (1:1000) Santa Cruz Biotechnology RRID:AB_632234
Rabbit anti-Tlx3 (1:10,000) Carmen Birchmeier Muller et al. 2002
Rabbit anti-Homer1 (1:2000) Synaptic Systems RRID:AB_2120990
Rat anti-mCherry (1:1000) Thermo Fisher Scientific RRID:AB_2536611
AlexaFluor-488-conkey anti-chicken
(1:800)
Jackson ImmunoResearch
Laboratories
RRID:AB_2340376
AlexaFluor-488-donkey anti-goat
(1:800)
Jackson ImmunoResearch
Laboratories
RRID:AB_2340430
AlexaFluor-488-donkey anti-rabbit
(1:800)
Jackson ImmunoResearch
Laboratories
RRID:AB_2340619
AlexaFluor-647-donkey anti-goat
(1:800)
Jackson ImmunoResearch
Laboratories
RRID:AB_2340437
AlexaFluor-647-donkey anti-guinea
pig (1:800)
Jackson ImmunoResearch
Laboratories
RRID:AB_2340477
AlexaFluor-647-donkey anti-rabbit
(1:800)
Jackson ImmunoResearch
Laboratories
RRID:AB_2340626
Cy3-donkey anti-goat (1:800) Jackson ImmunoResearch
Laboratories
RRID:AB_2340413
Cy3-donkey anti-mouse (1:800) Jackson ImmunoResearch
Laboratories
RRID:AB_2315777
Cy3-donkey anti-rabbit (1:800) Jackson ImmunoResearch
Laboratories
RRID:AB_2307443
Cy3-donkey anti-rat (1:800) Jackson ImmunoResearch
Laboratories
RRID:AB_2340667
DyLight 549-donkey anti-guinea pig
(1:800)
Jackson ImmunoResearch
Laboratories
Catalog #706-506-148
Biotin-donkey anti-rabbit (1:300) Thermo Fisher Scientific RRID:AB_228212
Fluorescent conjugates (dilution)
Pacific Blue-Streptavidin (1:1000) Thermo Fisher Scientific Catalog #S11222
AlexaFluor-647-Isolectin GS-IB4
(1:500)
Thermo Fisher Scientific RRID:SCR_014365
RNAscope ISH probes
Mm-Grp Advanced Cell Diagnostics Catalog #317861
Mm-Grp-C2 Advanced Cell Diagnostics Catalog #317861-C2
Mm-Grpr-C2 Advanced Cell Diagnostics Catalog #317871-C2
tdTomato Advanced Cell Diagnostics Catalog #317041
Viruses
AAV1.hSyn.flex.hM3Dq-mCherry Penn Vector Core Foster et al., 2015
SAD.RabiesG.eGFP (EnvA) Custom production Albisetti et al., 2017
H129TK-TT Enquist Lynn, CNNV Lo and Anderson, 2011
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NA  20 Plan-apochromat objectives. To
quantify the number of cells, at least 3 animals
and three sections per animal were analyzed.
Cell counting was performed using the Im-
ageJ Cell Counter plug-in.
Dendritic morphology of GRP neurons was
studied using 3D imaging of cleared lumbar
spinal tissue. For tissue clearing, a modified
passive CLARITY (Chung and Deisseroth,
2013) protocol was used. In brief, GRP::cre
mice crossed to the ROSA26lsl-TVA reporter
were intraspinally injected with EnvA-pseu-
dotyped rabies virus (SAD.RabiesG.eGFP
(EnvA)) and perfused with 4% PFA 5 d after
virus injection. Lumbar spinal tissue dissected
and postfixed overnight in 4% PFA at 4°C fol-
lowed by a subsequent overnight incubation at
4°C in a PBS solution containing 4% acryl-
amide (Bio-Rad) and 0.25% VA-044 (No-
vachem). Spinal cord tissuewas then incubated
for 3 h at 37°C for acrylamide polymerization
and incubated overnight in clearing solution as
follows: 200mM SDS (Sigma-Aldrich), 200mM
boric acid (Sigma-Aldrich), pH 8.5, at 37°C on
a shaker at 180 rpm. Spinal tissue was washed
three times in PBS, incubated in 88% Histo-
denz (Sigma-Aldrich) solution in PBS (refrac-
tory index adjusted to 1.457) overnight, and
mounted in the same solution. Imaging was
performed on a TCS SP8 upright multiphoton
microscope equipped with NA 1.0 25 water
objective, HyD-RLD detectors (Leica Micro-
systems) and InSigthDSDual (Spectraphysics)
NIR laser tuned to 950 nm for eGFP excitation.
Data were segmented using Imaris version 8
(Bitplane), and single neurons were manually
selected for the size calculations and manual
classification. In total, 32 cells from two mice
were analyzed.
In situ hybridization. Spinal tissue used for
ISH was dissected from 6- to 12-week-old
mice, collected in 1.5 ml Eppendorf tubes, and
immediately frozen in liquid nitrogen. Tissue
was embedded in NEG50 frozen section me-
dium (Richard-Allen Scientific), cut into 20
m sections, and hybridized using DIG-
labeled riboprobes (overnight at 70°C) or with
the probes designed for RNAscope Fluores-
cent Multiplex ISH listed in Table 1. Tissue
hybridized using DIG-labeled riboprobes was
incubated with sheep anti-DIG-alkaline-phosphatase-conjugated antibody
(1:1500, Roche Diagnostics) and developed in NTMT solution (0.1 M Tris,
pH9.5, 0.1 MNaCl, 50mMMgCl2, 0.1%Tween 20) containing 0.035mg/ml
NBT (AppliChem) and 0.017mg/ml BCIP (AppliChem) for 3 d.
Intrathecal injections of diphtheria toxin (DTX). Mice were anesthe-
tizedwith isoflurane, and a small skin incisionwas performedon the back
of the animal; 3l of 5 ng/l DTX suspension (in filtered 0.9%NaCl, 8%
dextrose) was injected through the intervertebral space L1/L2 using a
10l Hamilton syringe with a needle adapter to limit the injection depth
to 2.5 mm.
Intraspinal virus injections. Intraspinal virus injections were made in
isoflurane-anesthe-
tizedmice using amotorized stereotaxic frame (David Kopf Instruments
and Neurostar). Three separate unilateral injections of 300 nl each were
performed at a depth of 300musing glass micropipettes connected to a
PHD ultra nanomite syringe pump (Harvard Apparatus) as described
previously (Albisetti et al., 2017; Haenraets et al., 2018). The following
viruses were used: for chemogenetic activation, AAV1.hSyn.flex.
hM3Dq-mCherry (6.5 1012 IU/ml); for dendritic morphology analy-
ses, SAD.RabiesG.eGFP (EnvA, 1.5 107 IU/ml); and for anterograde
tracing, H129TK-TT. For the latter replication competent virus, no
titer was available. For details on the viruses, see Table 1.
Behavioral analyses. All behavioral tests were performed during light
phase. The experimenter was blinded for the genotype of the mice. For
nociception assays, themicewere placed into Plexiglas boxes and allowed
to adapt to the new environment for 30 min. In pharmacogenetic exper-
iments, behavioral pain tests were performed 1–2 weeks after surgery,
from 1.5 to 2.5 h after intraperitoneal clozapine N-oxide (CNO, Enzo
Life Sciences) injection (2 mg/kg). Mechanical withdrawal thresholds
were assessed using an electronic von Frey anesthesiometer (IITC), and
the maximal force applied on the mouse paw was restricted to 6 g. With-
drawal latencies to noxious heat were assessed using Hargreaves test
apparatus (IITC) with a temperature-controlled glass platform set to
30°C. Withdrawal latencies to noxious cold were assessed cooling the
5-mm-thick borosilicate glass platform directly under the mouse hind-
paw using a cold probe (powdered dry ice compressed into a 1 cm large
syringe) (Brenner et al., 2012). ForHargreaves and cold tests, cutoff times
were set to 32 and 24 s, respectively. For von Frey, Hargreaves, and cold
Figure 1. Characterization of GRP-cre-expressing neurons. A, Immunofluorescence staining on a transversal section of lumbar
spinal cord of GRP::cremice showed GRP-tdTom neurons to be located in laminae I and II of the spinal dorsal horn, dorsally to the
PKC neurons. B, GRP-tdTom neurons partially colocalize with the termination area of IB4 primary afferents. C, Double ISH
shows that GRP-tdTom expression is restricted to Grp-expressing neurons. Arrowheads indicate a double-labeled neuron. D,
Quantification of C. E, Double ISH shows thatGrp- andGrpr-expressing neurons are twononoverlapping neuronal populations. Full
arrowheads indicate Grp-expressing neurons. Empty arrowheads indicate Grpr-expressing neurons. F, Immunostaining showing
that GRP-tdTom neurons express the excitatory neuronal markers Lmx1b but not the inhibitory marker Pax2. G, Quantitative
colocalization studied on spinal sections of GRP::cre; ROSA26lsl-tdTommice stainedwith antibodies to Lmx1b, Pax2, Tlx3, PKC, and
calbindin (CB). H, Section of a lumbar DRG obtained from a GRP::cre;ROSA26lsl-tdTom mouse showing no tdTom expression in
primary sensory neurons. Scale bars 100m in overviews and 20m in higher magnifications (A, B, C, E, F ), and 100m (H ).
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tests, eightmeasurements were taken per hind-
paw in 5–10 min intervals, and average hind-
paw withdrawal thresholds were calculated for
each mouse. Motor coordination was tested
using a rotarod instrument (IITC) that linearly
accelerated from 0 to 40 rpm over 5 min, and
the latency to fall was measured for each
mouse. Two training sessions were performed
before the test experiment. Six measurements
were taken for each mouse. For pinprick test
and brush tests, measurements were taken by
stimulating the plantar surface of the mouse
hindpaw with a blunted G26 needle and a soft
paint brush, respectively. Ten measurements
were taken at the interval of 2 min, and re-
sponses were scored as “0” for no reaction or
“1” if the animal responded. For behavioral ex-
periments on itch, mice were placed into Plexi-
glas cylinders for 30 min of adaptation. For
intradermal injection of pruritogens, the mice
were restrained without anesthesia, and 10 l
of pruritogen was injected intracutaneously
into the skin above the calf using a 30 gauge
needle. The injection site was shaved 1 d before
the experiment. The following pruritogens
(dissolved in 0.9% filtered saline) were used:
chloroquine diphosphate salt (8 g/l, Sigma-
Aldrich), histamine (10 g/l, Sigma-Aldrich),
-methyl serotonin maleate salt (2 g/l,
Sigma-Aldrich), and SLIGRL-NH2 (6.57 g/
l, Abcam). The mice were videotaped for 30
min after the injection of the pruritogen, and
the biting time directed toward the injected
site was quantified. In pharmacogenetic ex-
periments, mice were returned for 1 h to
their home cage immediately after intraperi-
toneal CNO injection (2 mg/kg). Mice were
then allowed to adapt for 15 min and then
videotaped for 45 min to assess CNO-
induced itch behavior. Chloroquine diphos-
phate salt (8 g/l) and histamine (10 g/
l) were injected intracutaneously 2 h after
CNO injection, and mice were videotaped
for 30 min immediately after pruritogen ad-
ministration. All the recordings were per-
formed in the absence of the experimenter,
and biting time was analyzed offline. In
pharmacogenetics experiments that tested
the dose dependence of CNO (0.7 mg/kg, 0.1
mg/kg, 0.02 mg/kg), and in all nociception
and itch assays, data acquisition started 75
min after CNO administration.
Electrophysiology and optogenetics. Trans-
verse 400-m-thick spinal cord sliceswere pre-
pared from 4- to 5-week-old mice as described
previously (Dugue´ et al., 2009; Punnakkal et
al., 2014). Whole-cell patch-clamp experi-
ments were made at room temperature using
an EPC 9 amplifier (HEKA Elektronik) con-
trolled with Patchmaster acquisition software.
GRP-eGFP-positive neurons were identified
by their green fluorescence in slices prepared
from MrgprA3::cre;GRP::eGFP;ROSA26lsl-ChR2
triple transgenic mice. During recordings,
slices were continuously superfused at the rate
of 1–2 ml/min with ACSF containing the fol-
lowing (in mM): 120 NaCl, 2.5 KCl, 1.25
NaH2PO4, 26 NaHCO3, 5 HEPES, 1 MgCl2, 2
CaCl2, and 14.6 glucose, pH 7.4, equilibrated
Figure 2. Morphology and MrgprA3 primary sensory input of GRP-cre-expressing neurons. A, Examples of two GRP central
neurons form a spinal cord of GRP::cre ROSA26lsl-TVA mice infected with SAD.RabiesG.eGFP (EnvA) virus. The morphology of the
same cells is shown in the dorsoventral (left) and mediolateral view (right). Scale bars, 20m. B, Quantification of the morpho-
logical analysis of GRP neurons. C, Immunofluorescence staining of a lumbar spinal cord section of GRP::eGFP mice showing
GRP-eGFP colocalization with the excitatory marker Lmx1b in lamina II. Arrowheads indicate examples of colocalization of GRP-
eGFP and Lmx1b immunoreactivity. Scale bar, 100 m. D, Quantitative analysis verified that GRP-eGFP neurons and GRP-cre
neurons exhibit similar neurochemical characteristics (compare Fig. 1G). In bar charts, data are mean SEM. E, Overview of the
spinal dorsal horn of anMrgprA3-cre; GRP::eGFP; ROSAlsl-tdTom mouse. The termination area of MrgprA3-positive primary sensory
neurons largely overlapswith the locationwhere theGRP-eGFP cells are located. Scale bar, 100m. F, High-magnification images
of a GRP-eGFP cell receiving direct synaptic input fromMrgprA3-positive fibers. Arrowheads indicate MrgprA3-positive excitatory
synaptic contacts onto a GRP-eGFP cell. Scale bar, 20m. G, Schematic showing optogenetic activation of MrgprA3-expressing
primary afferent terminals (MrgprA3-ChR2) and targeted recordings from eGFP-positive GRP neurons (GRP-eGFP). H, Superposi-
tion of 20 consecutive light-evoked EPSCs traces recorded fromGRP-eGFP neurons. Blue area represents 473 nm, 4ms, 0.1 Hz. Gray
represents individual responses. Black represents average response. I, J, Dot plots illustrate latency (I ) and jitter (J ) of light-elicited
EPSCs recorded from GRP-eGFP cells (n 6, from 5 animals). Circles represent individual cells. Error bars indicate SEM.
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with 95% O2/5% CO2. Patch pipettes (borosilicate glass; 3.5–4.5 M)
were filled with intracellular solution containing the following (in mM):
130 potassium gluconate, 5 NaCl, 1 EGTA, 10 HEPES, 5 Mg-ATP, 0.5
Na-GTP, pH 7.35 (290–300 mosm/L). Membrane potentials were cor-
rected for a liquid junction potential of 15.2mV.Access resistance of each
neuron was continuously monitored with short hyperpolarizing voltage
steps. Optogenetic stimulation of MrgprA3-positive terminals was done
with field illumination through a 40water-immersion objective using a
Polychrome V monochromator (TILL Photonics). MrgprA3-positive
terminals were stimulated with brief, 4-ms-long pulses of blue light
(473 5 nmwave lengths, 1.15 mW). Average failure rates	5% (Doyle
andAndresen, 2001) and jitters (intraneuronal SDof EPSC latency)1.6
ms (Wang and Zylka, 2009) were used as criteria to classify light-evoked
EPSCs as monosynaptic. The latency was calculated between the onset of
light commands and the onset of EPSCs. Electronic andmechanical delay
of the system was calculated to be 3.38 ms and was subtracted from the
latency values. Light-evoked EPSCswere recorded at holding potential of
70 mV.
Experimental design and statistical tests.All experiments were designed
to allow comparisons between exactly two groups. Statistical compari-
sons were made using unpaired t tests (GraphPad Prism version 5 for
Windows, GraphPad Software). All data are given as mean SEM. Re-
sults of statistical tests are given as the t score (t) and the  error (p). p
values0.05 were considered statistically significant. Numbers of exper-
iments (cells or mice) are provided in Results and in the figure legends.
All experiments were done inmale mice. All numerical data are available
as Excel files, including the data that support the findings of this study
(www.G-Node.org; identifier doi: 10.12751/g-node.50baa6).
Results
To examine the integration of GRP neurons in dorsal horn neu-
ronal circuits and to investigate their potential role in itch and
pain-related behaviors, we used GRP::cre BAC transgenic mice.
We first characterized the spinal expression pattern of the GRP::
cre transgene and crossed GRP::cremice to cre-dependent tdTo-
mato (Ai14 tdTom) reporter mice. Lumbar spinal cord sections
prepared from adult (6- to 10-week-old mice) double transgenic
offspring revealed that GRP-tdTom-positive neurons were re-
stricted to lamina II of the superficial dorsal horn. Most GRP-
tdTom-positive neurons were located ventral to the calcitonin
gene-related peptide (CGRP)-positive layer and dorsal to the
PKC neuron layer partially overlapping with the termination
area of IB4-positive sensory nerve fibers (Fig. 1A,B). Double ISH
experiments (7 sections from 2 mice) verified that GRP-tdTom
was only present in GrpmRNA-positive neurons (94.4 1.5%),
but only 24.9 2.6% of neurons with Grp ISH signals were also
tdTom-positive (Fig. 1C,D). Double ISH experiments using
probes for Grp and its receptor, the Grpr, demonstrated in addi-
tion that Grp and Grprmarked distinct dorsal horn neuron pop-
ulations (Fig. 1E). Subsequent neurochemical characterization of
spinal GRP-tdTom neurons (8–14 sections from 3–5 mice were
used to quantifyGRP-tdTomcolocalizationwith each of the neu-
rochemicalmarker) showed that 85.8 2.2% and 78.8 2.4%of
these neurons coexpressed, respectively, the excitatory interneu-
ronmarkers Lmx1b andTlx3,whereas virtually no overlap (0.5
0.5%) with the inhibitory interneuron marker Pax2 was found
(Fig. 1F,G); 29.1 2.5% of GRP-tdTom neurons expressed cal-
bindin, and only 3.5 1.4% expressed PKC (Fig. 1G). NoGRP-
tdTom was detected in the DRGs (16 sections from 4 mice)
(Fig. 1H).
We next investigated the dendritic morphology of dorsal
horn GRP neurons (32 cells from 2 mice). The combination of
sparse neuronal labeling and large-volume imaging allowed
the characterization of dendritic tree architecture in three
dimensions. The sparse labeling was achieved by injecting
lumbar spinal cords of the GRP::cre; ROSA26lsl-TVA double
transgenic mice with a glycoprotein-deficient eGFP reporter ra-
bies virus (SAD.RabiesG.eGFP (EnvA)). Because no trans-
complementation of the glycoprotein-deficient rabies virus was
done, secondary infection did not occur and only few GRP-cre
neurons expressed eGFP. The lumbar spinal tissue was then
cleared usingmodified passive CLARITY, and eGFP fluorescence
was visualized in the whole mounts with 2-photon microscopy
technique. Tissue volumes of 1.0 mm 0.5 mm 0.6 mm (ros-
trocaudalmediolateral dorsoventral) size were imaged. Be-
cause of the sparse labeling, it was possible to segment individual
cells from the visualized volumes and assess the full dendritic
arbor architecture in 3D. The vast majority of labeled neurons
displayed a central cell-like morphology (Fig. 2A,B; Movie 1).
Results from several behavioral studies indicate that GRP and
its receptor the GRPR play a critical role in itch and suggest that
GRP-expressing neurons are part of an itch processing circuit in
the spinal dorsal horn (Y.G. Sun and Chen, 2007; Y.G. Sun et al.,
2009; S. Sun et al., 2017). To investigate whether GRP neurons
receive synaptic input from MrgprA3-positive pruritoceptive
sensory fibers, we usedGRP::eGFP transgenic mice. Immunoflu-
orescence analyses (7–9 sections from 3 mice were used to quan-
tify GRP-eGFP colocalization with each of the neurochemical
marker) verified that GRP-eGFP neurons exhibited neurochem-
ical features that were very similar to the one of the GRP-cre
neurons characterized above (73.9 7.5% colocalization with
Lmx1b, 70.5  5.3% with Tlx3, 11.2  1.8% with PKC,
21.0  5.7% with calbindin and no overlap with Pax2) (Fig.
2C,D; see also Fig. 1F,G). We next prepared lumbar spinal cord
sections from MrgprA3::cre; GRP::eGFP; ROSA26lsl-tdTom triple
transgenic mice. These sections revealed that MrgprA3-positive
pruritoceptors terminate mainly in lamina II (i.e., in the same
lamina where most GRP-eGFP neurons are located) (Fig. 2E).
Staining of sections from these mice with antiserum against
HOMER, a postsynaptic marker of glutamatergic synapses
(Gutierrez-Mecinas et al., 2016b), and antiserum against vGluT2
indicates that MrgprA3-positive fibers form synaptic contacts
withGRP-eGFPneurons in lamina II of the dorsal horn (Fig. 2F).
To functionally demonstrate the presence of synaptic connec-
tions, we prepared transverse slices of the lumbar spinal cord
from MrgprA3::cre; GRP::eGFP; ROSA26lsl-ChR2 triple transgenic
mice. In these slices, we performed whole-cell recordings from
Movie1. Dendriticmorphology of dorsal hornGRP-cre neurons visu-
alized using the CLARITY technique in a whole mount of the lumbar
spinal cord of aGRP::cremouse injectedwith SAD.RabiesG.eGFP virus.
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GRP-eGFP neurons to detect postsynaptic current responses
upon optogenetic stimulation of MrgprA3 fibers (Fig. 2G); 4 ms
blue light stimulation evoked EPSCs in 6 of 28 GRP-eGFP neu-
rons (from 7mice). Figure 2H shows individual EPSCs in a GRP-
eGFP neuron that responded to optogenetic stimulation of
MrgprA3 fibers. Light-evoked EPSCs had on average amplitudes
of 126  57 pA (n  6 neurons from 5 mice), occurred with
latencies of 12.8 0.18 ms, jitters of 1.08 0.19 ms (Fig. 2 I, J),
and with low failure rates of 4.1  2.7% (n  6). Although the
observed latencieswere longer than latencies typically observed after
electrical stimulation, their range is similar to that previously re-
ported for light-evoked synaptic transmission between superficial
dorsal horn neurons and unmyelinated MrgprD-positive fibers
(Wang and Zylka, 2009). The low failure rate and the small jitter
Figure3. DTX-mediated ablation of GRP-cre neurons.A, Strategy for targetedDTX-mediated ablation of GRPneurons.B, ISH following intrathecal injection of DTX on spinal tissue of cre-negative
control and GRP::cre;ROSA26lsl-iDTR mice. Scale bar, 50m. C, Quantification of B, showing that Grp-expressing neurons are reduced by 29% following DTX-mediated ablation. D, Coronal brain
sections from GRP::cre; ROSA26lsl-tdTom mouse showing abundant GRP-tdTom expression in several brain areas. Arrowheads indicate facial nucleus and lateral vestibular nucleus (DI), ventral
posterior nucleus of the thalamus (DII), and insular cortex (DIII). Scale bar, 1 mm. E, Quantification of GRP-tdTom neurons at supraspinal sites following intrathecal injection of DTX in GRP::cre;
ROSA26lsl-tdTom (tdTom/iDTR) control mice and GRP::cre;ROSA26lsl-tdTom; ROSA26lsl-iDTR (tdTom/iDTR) mice. Data are normalized by setting the number of cells counted in GRP::cre;
ROSA26lsl-tdTom control mice as 100%. 7D, Facial nucleus; Lve, lateral vestibular nucleus; VP, ventral posterior nucleus of the thalamus; IC, insular cortex. F, Confocal image of spinal dorsal horn
following intrathecal injection of DTX inGRP::cre;ROSA26lsl-tdTom andGRP::cre;ROSA26lsl-tdTom;ROSA26lsl-iDTRmice. Scale bars, 50m.G, Same as in E, but for different spinal cord segments. S, Sacral;
L, lumbar, T, thoracic; C, cervical spinal cord. In all bar charts, data are mean SEM.
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(1.6ms) (WangandZylka, 2009) in5of 6neuronsprovide further
support for the monosynaptic nature of these signals.
We then went on with experiments to assess the behavioral
consequences of manipulation of GRP neurons. We used two
complementary strategies: DTX-mediated ablation and chemo-
genetic activation with the hM3Dq designer receptor exclusively
activated by designer drugs (DREADDs). To this end, we first
crossed theGRP::cremice with mice that express the DTX recep-
tor (DTR) as a cre-dependent (“inducible”) transgene (iDTR
mice) to obtain triple transgenic GRP::cre;ROSA26lsl-tdTom;
ROSA26lsl-iDTR mice. Because GRP neurons are also present at
multiple supraspinal sites (http://www.gensat.org/cre.jsp), we
chose to inject DTX (15 ng in 3 l) intrathecally in a hyperbaric
(8% dextrose) solution to restrict ablation of GRP neurons to the
spinal cord (Fig. 3A). Ten days after injection, we quantified the
number of Grp mRNA-expressing neurons with ISH. We ana-
lyzed 18 and 72 sections from 3Grp::cre-negative and 13Grp::cre-
positive mice. Average numbers of GrpmRNA-positive neurons
per section were 89.5 3.9 and 63.8 1.8, for Grp::cre-negative
and 13 Grp::cre-positive mice, respectively (t score  5.94, p 
2 108, unpaired t test), corresponding to an average decrease
of Grp mRNA-positive neurons by 29% (Fig. 3B,C). This per-
centage is consistent with the expression of GRP-cre in
25% of
the GrpmRNA-positive neurons (compare also Fig. 1C). In line
with previous reports about the supraspinal distribution of GRP
neurons (Wada et al., 1990), we foundGRP-tdTom-positive neu-
rons (in GRP::cre;ROSA26lsl-tdTom mice) at various sites in the
hindbrain and forebrain, including at least two areas relevant to
central pain processing, that is, in the ventral posterior thalamic
nuclei and the insular cortex (Fig. 3D; Table 2). We then com-
pared the numbers of GRP-tdTom neurons after intrathecal
DTX injection in brain sections of GRP::cre;ROSA26lsl-tdTom;
ROSA26lsl-iDTR (tdTom/iDTR) mice (9 sections per area from
3 mice) and of GRP::cre;ROSA26lsl-tdTom (tdTom/iDTR) con-
trol mice (6 sections per area from 2 mice). Percentages of GRP-
tdTom neurons per section in DTX-injected iDTR-positive mice
relative to DTX-injected but iDTR-negative control mice were
99.7 10.1% (t 0.02, p 0.99, unpaired t test), 85.8 5.3%
(t 0.81, p 0.43), 79.9 7.6% (t 1.54, p 0.15), and 98.7
14.9% (t  0.06, p  0.96), for the facial nucleus, lateral vestib-
ular nucleus, ventral posterior nucleus of the thalamus, and in-
sular cortex, respectively (Fig. 3E). In the spinal cord, ablation
occurredwith a caudorostral gradient. The percentage of remain-
ing GRP-tdTom neurons was lowest in the sacral (36.8 4.3%,
t  5.93, p  1  105), intermediate in the lumbar (49.3 
4.8%, t  5.23, p  5  105) (Fig. 3F) and thoracic segments
(47.4  7.8%, t  3.71, p  0.001), and highest in the cervical
segment (59.2 8.8%, t 2.38, p 0.028) (Fig. 3G).
We then continuedwith behavioral experiments to investigate
the responses of spinal GRP neuron-ablated mice to several pru-
ritoceptive stimuli (chloroquine, histamine, serotonin, and the
PAR2 agonist SLIGRL) injected intracutaneously into the left calf
(Fig. 4). Ten days after DTX injection, we observed a reduction in
aversive behaviors (biting of the injected site) relative to GRP::
cre-negative ROSA26lsl-iDTR transgenic mice for three of the four
pruritogens. The times spent biting were as follows: 154  18 s
(n  9) versus 104  11 s (n  9) for chloroquine-injected
GRP::cre-negative andGRP::cre-positivemice (t 2.30, p 0.03,
unpaired t test); 382  40 s (n  8) and 272  30 s (n  9) for
histamine-injectedmice (t 2.21, p 0.04); and 470 53 s (n
10) and 313 37 s (n 10) for serotonin-injectedmice (t 2.45,
p  0.02) (Fig. 4A–C). The incomplete block of itch responses
very likely reflects that	30%of theGrpmRNA-positive neurons
express cre. Unexpectedly, we did not observe a reduction in time
spent biting for PAR2 (SLIGRL)-induced itch (290.7  31.8 s,
n 12; vs 336 37 s, n 9; for SLIGRL-injected mice; t 0.94,
p  0.36, unpaired t test) (Fig. 4D). Given that several previous
reports (Y.G. Sun and Chen, 2007; Y.G. Sun et al., 2009; Wan et
al., 2017) found a reduction of SLIGRL-induced itch after inter-
fering with GRP signaling pathways through different strategies,
it is likely that, in our study, the GRP neurons remaining after
DTX treatment account for the retained PAR2-induced prurito-
ceptive behavior.
Next, we used the same experimental approach to investigate
potential effects of nociceptive (noxious heat, noxious cold, pin-
prick) and tactile (brush and von Frey) stimuli. Spinal GRP
neuron-ablated mice and GRP::cre-negative control mice exhib-
ited nearly identical response latencies and response scores (Har-
greaves test latencies: 17.2 1.2 s, n 11; vs 15.1 1.4 s, n 9;
for GRP::cre-negative vs GRP::cre-positive mice; t  1.14, p 
0.27, unpaired t test; cold plantar test latencies: 9.9  1.1 s, n 
11; vs 8.8  0.6 s, n  9; t  0.85, p  0.41; pin prick response
score: 87.5 6.2%, n 8; vs 90.0 3.8%, n 7; t 0.33, p
0.75; von Frey test threshold: 3.7 0.2 g, n 11; vs 3.5 0.2 g,
n 9; t 0.87, p 0.40; brush test response score: 81.3 6.9%,
n 8; vs 95.7 3.0%, n 7; t 1.82, p 0.09) (Fig. 4E–I). No
impairment of motor coordination occurred in the rotarod test.
Latencies to fall were 134 14 s (n 11) and 146 7 s (n 9),
for control and GRP neuron ablated mice, respectively (t 0.76,
p 0.46, unpaired t test, data not shown).
In the second, complementary approach, we locally activated
spinal GRP neurons using an excitatory chemogenetic strategy.
The left lumbar dorsal horn of GRP::cre transgenic mice was in-
jected with an adeno-associated virus (AAV) carrying a cassette
for cre-dependent expression of the excitatoryDREADDhM3Dq
(Alexander et al., 2009) fused in frame with red fluorescent pro-
Table 2. Distribution of GRP-tdTom-positive neurons in themouse braina
Brain area Region
Cortical plate Lateral orbital cortex (LO)
Ventral orbital cortex (VO)
Agranular insular cortex (AI)
Anterior cingulate cortex (Cg)
Primary motor cortex (M1)
Secondary motor cortex (M2)
Somatosensory cortex (S1)
Field CA3 hippocampus (CA3)
Cerebral nuclei Accumbens nucleus (Acb)
Hypothalamus Dorsomedial hypothalamic nucleus (DM)
Suprachiasmatic nucleus (SCH)
Fields of Forel (FF)
Thalamus Anteroventral thalamic nucleus (AV)
Anteromedial thalamic nucleus (AM)
Ventral posterolateral thalamic nucleus (VPL)
Ventral posteromedial thalamic nucleus (VPM)
Mediodorsal thalamic nucleus (MDL)
Centrolateral thalamic nucleus (CL)
Medial geniculate nucleus (MG)
Midbrain Anterior pretecal nucleus (APT)
Nucleus of the optic tract (OT)
Superior colliculus (SuG)
Periaqueductal gray (PAG)
Oculomotor nucleus (3N)
Medulla Superior vestibular nucleus (SuVe)
Lateral vestibular nucleus (Lve)
Vacial nucleus (7N)
aData are from 2mice.
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tein mCherry (Fig. 5A). hM3Dq permitted selective activation of
GRP neurons by CNO. Seven days after virus injection, mCherry
expression was detected in lamina II neurons of the injected dor-
sal horn (Fig. 5B). Before CNO injection, expression of hM3Dq
did not induce any scratching or biting behavior beyond what
was observed in cre-negative AAV1.hSyn.flex.hM3Dq-mCherry-
injected mice (Fig. 5C). However, the same mice responded with
intense aversive behaviors (biting of the skin territories inner-
vated by the injected spinal segment) when injected systemically
(intraperitoneally) with CNO (2 mg/kg) (Fig. 5C,D). No such
effects were observed in cre-negative mice that had undergone
the same virus injection, strongly suggesting that activity of spinal
GRP neurons evokes profound aversive behaviors reminiscent of
responses elicited by acute pruritic stimuli. Time spent biting was
16.6 8.5 s (n 9) and 195 35 s (n 6), forGRP::cre-negative
and GRP::cre-positive mice (t 6.03, p 4 105, unpaired t
test) (Fig. 5C,D).
Our results described above are consistent with a specific role
of spinal GRP neurons in itch. This specificity has recently been
challenged when S. Sun et al. (2017) proposed that spinal GRP
neurons would also contribute to nociceptive signal relay. Unlike
itch relay, this nociceptive relay would follow a bell-shaped re-
sponse curve with significant contributions occurring only at low
activity levels.More intense activity of spinal GRPneuronswould
close the spinal pain gate. To rule out the possibility that we had
missed an effect on pain behaviors because our chemogenetic
stimulation was too strong, we investigated possible potentiating
actions of CNO on responses evoked by nociceptive or prurito-
ceptive stimulation at a later time point when “spontaneous”
CNO-induced pruritoceptive responses had subsided (Fig.
5C,E–K, red and blue traces). One group of mice was challenged
with either chloroquine (80 g in 10 l) or histamine (100 g in
10 l) to assess a potential facilitation of itch responses. Re-
sponses to both pruritogens were significantly higher in the cre-
positive AAV1.hSyn.flex.hM3Dq-mCherry injected mice than in
cre-negative mice, indicating that at this time point the remain-
ing CNO concentration was high enough to increase the excit-
ability of the GRP neurons (times spent biting for chloroquine:
135  21 s, n  14; vs 269  31 s, n  11; t  3.78, p  0.001,
unpaired t test; forGRP::cre-negative andGRP::cre-positivemice,
respectively; for histamine: 189 30 s, n 12; vs 361 58 s, n
11; t  2.73, p  0.01) (Fig. 5C,E,F). By contrast, we failed to
detect a change in the responses to noxious stimuli (Hargreaves
test latencies: 24.1 2.0 s,n 12; vs 20.1 1.3 s,n 12; t 1.38,
p  0.18, unpaired t test, for GRP::cre-negative and GRP::cre-
positive mice, respectively; noxious cold test latencies: 12.7 
1.2 s, n 12; vs 13.8 1.2 s, n 11; t 0.69, p 0.49; pin-prick
response score: 89.2 5.7%, n 12; vs 92.5 3.3%, n 12; t
Figure 4. Behavioral effects of DTX-mediated ablation of GRP-cre neurons. A–D, Reduced itch responses to chloroquine, histamine, and serotonin but not SLIGRL following DTX-mediated
ablation of GRP neurons. E–I, Unaltered thermal and mechanical nociceptive responses in GRP neurons ablated mice. Circles represent measurements from individual mice. Error bars indicate
mean SEM.
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Figure 5. Chemogenetic activation of GRP-cre neurons. A, Strategy for DREADD-mediated activation of GRP-cre neurons and timeline of the experiment design. B, Spinal section showing
cre-dependent hM3D-mCherry expression inGRP-cre neurons. Scale bar, 100m.C, Time course of itch behavior before and after DREADD-mediated activation of GRP-cre neurons. CNO induces itch
response in GRP::cremice intraspinally injected with AAV1.hSyn.flex.hM3Dq-mCherry but not in control cre-negativemice. Pruritogens histamine and chloroquine were injected intradermally 120
min after CNO treatment. Chemogenetic activation of GRP neurons increases pruritogen-induced biting behavior. Biting behavior was quantified in intervals of 5 min. (Figure legend continues.)
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0.51, p  0.62) (Fig. 5G–I), confirming the lack of an effect of
GRP neuron activation on pain. Similarly, no changes were ob-
served for innocuous tactile stimulation (von Frey thresholds:
4.5 0.3 g, n 10; vs 3.9 0.4 g, n 9; t 1.47, p 0.16; brush
response score: 78.0 8.1%, n 10; vs 84.4 6.3%, n 9; t
0.62, p 0.55) (Fig. 6 J,K). No impairment of motor coordina-
tion was observed in the rotarod test. Latencies to fall were 103
13 s and 127 11 s, for CNO-injected cre-negative (control) and
cre-positive mice, respectively (t 1.34, p 0.2, unpaired t test,
data not shown).
In a second approach, we used different doses of CNO (0.7,
0.1, and 0.02 mg/kg, i.p.) and compared their effects on sponta-
neous itch-like behavior.We found a dose-dependent increase in
the times spent biting (0.7 mg/kg: 35.7 13.1 s, n 6 GRP::cre-
negative; vs 227  49 s, n  6 GRP::cre-positive mice; t  3.79,
p 0.004, unpaired t test; 0.1mg/kg: 31.3 7.1 s, n 6; vs 139
41 s, n 6; t 2.61, p 0.03; 0.02 mg/kg: 17.7 7.2 s, n 6; vs
41.5 18.2 s, n 6; t 1.22, p 0.25) (Fig. 5L), but no effects
on response latencies in the Hargreaves test (0.7 mg/kg: 16.9 
3.0 s, GRP::cre-negative; vs 16.8  2.3 s, GRP::cre-positive mice;
t  0.02, p  0.99, unpaired t test; 0.1 mg/kg: 12.1  1.4 s vs
13.3 1.6 s, t 0.52, p 0.61; 0.02mg/kg: 19.2 2.8 s vs 19.3
0.9 s, t 0.01, p 0.99, n 6 for all groups) (Fig. 5M). Together,
these results suggest that spinal GRP neurons do not exert an
apparent function in spinal pain control.
Finally, we used polysynaptic anterograde virus-based tracing
to investigate supraspinal CNS areas innervated by neuronal
pathways emerging from GRP neurons (Fig. 6). To this end, we
injected the cre-dependent H129TK-TT herpes virus variant
(Lo and Anderson, 2011) into the lumbar spinal cord of 3 GRP::
cre mice. H129TK-TT becomes recombined in cre-expressing
neurons to enable replication and tdTomato expression first in
the cre-expressing neurons and subsequently in all neurons con-
nected in an anterograde manner. Four to five days after HSV
injection, mice were perfused and coronal sections were taken at
240 m intervals. tdTom expression occurred at several distinct
supraspinal sites (Table 3). Among the tdTom-labeled sites were
the medial parabrachial nucleus, the rostral ventromedial me-
dulla, the ventrolateral periaqueducal gray, the red nucleus, the
dorsomedial hypothalamus, the sensory thalamic nuclei, the cen-
tral amygdala, and the somatosensory cortex (hindlimb region).
Several of these areas have previously been identified in func-
tional brain imaging experiments on itch (for review, see Forster
and Handwerker, 2014). Our findings thus confirm the results of
the imaging studies and further support the role of GRP neurons
in itch.
Discussion
The presence of peripheral sensory neurons whose activation
specifically elicits itch-like behavior (Liu et al., 2009; Mishra and
Hoon, 2013; Huang et al., 2018) and the enriched expression in
these neurons of receptors activated by pruritogens (Usoskin et
al., 2015; Nguyen et al., 2017) supports the concept of a “labeled
line” for itch at the level of the primary sensory neurons. Such a
4
(Figure legend continued.) Timeline on the x axis indicates the time fromCNO intraperitoneal
injection. D, Chemogenetic activation of spinal GRP-cre neurons induced itch response. Biting
behavior was quantified for 30 min starting 75 min after CNO injection. E, F, Increased
histamine- and chloroquine-induced itch behavior following chemogenetic activation of spinal
GRP-cre neurons. Biting behaviorwas quantified from120min after CNO treatment, for 30min.
G–K, Unaltered nociceptive responses following chemogenetic activation of spinal GRP-cre
neurons. L, M, Dose-dependent induction of spontaneous pruritoceptive (biting) responses by
CNO, but no sensitization to heat in theHargreaves test.Measurementswere taken 75min after
CNO injection. Circles represent measurements from individual mice. Error bars indicate
mean SEM.
Figure 6. HSV-based anterograde tracing initiated from spinal GRP-cre neurons. Immunostaining on coronal brain sections of GRP::cremice intraspinally injected with HSV showing brain areas
receiving polysynaptic connections from GRP neurons, including the following: (A) somatosensory cortex hindlimb region (S1HL), (B) ventral posterolateral nucleus of the thalamus (VPL), (C)
dorsomedial hypothalamic nucleus (DMH), (D) central nucleus of the amygdala (CeA), (E) red nucleus magnocellular part (RMC), (F) ventrolateral periaqueductal gray (VLPAG), (G) medial
parabrachial nucleus (MPB), and (H) rostral ventromedial medulla (RVM). Scale bar, 200m.
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peripheral labeled line is in agreement with microneurography
experiments that revealed a specific class of C fibers that become
tonically active upon exposure to histamine (Schmelz et al.,
1997). Less clear is whether this labeled line also exists at the
spinal cord level. The well-established interaction of nociceptive
and pruritoceptive pathways at the level of spinal cord (Liu et al.,
2010; Kardon et al., 2014; S. Sun et al., 2017) has given rise to the
selectivity, as opposed to specificity, theory of itch (Ma, 2010).
Here, we have focused our efforts on the GRP-positive popula-
tion of dorsal horn neurons.Our study identifies these neurons as
a rather homogeneous population of lamina II excitatory in-
terneurons with a central cell-like morphology. These results are
generally in good agreement with several previous studies
(Gutierrez-Mecinas et al., 2014, 2016a; Solorzano et al., 2015; S.
Sun et al., 2017) that found that GRP expression defines a distinct
set of excitatory dorsal horn neurons. Our multicolor fluores-
cence confocal microscopy results and the optogenetic experi-
ments in spinal cord slices revealed that GRP neurons receive
excitatory synaptic input from theMrgprA3-positive population
of primary pruritoceptors. This innervation pattern correlates
well with our behavioral experiments in which we found that
manipulation of GRP neurons interfered with behavioral re-
sponses to pruritic stimuli but did not change response to acute
painful stimuli. They hence support previous studies that attrib-
uted to GRP receptors and GRPR-expressing neurons specific
roles in itch (Y.G. Sun and Chen, 2007; Y.G. Sun et al., 2009). As
such, our results support that the concept of a “labeled line” for
itch might extend from the periphery at least to second-order
spinal neurons. This is also supported by a recent study that
reported little capsaicin-sensitive (nociceptive) synaptic input
onto GRP neurons (Dickie et al., 2019). Nevertheless, all of the
above findings are consistent with selectivity theory of itch and
the well-established cross talk from nociceptive to pruritoceptive
relay pathways (Kardon et al., 2014).
Recently, the “leaky gate” model has been proposed as an
additional alternative to the labeled line or selectivity concepts
(S. Sun et al., 2017). This model proposes that GRP neurons
would receive input from sensory fibers that elicit itch sensations
and from other fibers that trigger pain responses. The GRP neu-
rons would then convey itch signals and low-intensity pain sig-
nals, whereas high-intensity pain signals would be blocked
through a GRP neuron-evoked feedforward inhibition. This
intensity-dependent feedforward inhibition would lead to a nor-
mal stimulus response curve for GRP neuron-mediated itch but
to a bell-shaped response curve for pain. In our experiments, we
did not find evidence for this scenario. One might argue that the
intensity of chemogenetic activation of GRP neurons in our ex-
periments was too strong to evoke pain responses. However, sub-
threshold activation of GRP neurons by CNO still only facilitated
responses to pruritoceptive, but not to nociceptive, stimuli (com-
pare Fig. 5L,M). Furthermore, our ablation experiments also
failed to provide evidence for an involvement of GRP neurons in
pain. Because both the study by S. Sun et al. (2017) and our study
used the same line ofGRP::cre BAC transgenicmice and the same
iDTRmouse line for ablation, differences in transgene expression
can largely be ruled out as an explanation of the different results.
One potentially relevant difference in the experimental design,
however, is the route of administration of DTX. In our experi-
ments, we injected DTX locally into the intrathecal space of the
lumbar spinal cord and in a hyperbaric solution to prevent diffu-
sion to the brain. S. Sun et al. (2017), by contrast, applied DTX
systemically via (intraperitoneal) injections. This difference may
be relevant, as the presence ofGRPneurons is not restricted to the
spinal cord. Indeed, theGRP::cremouse line used in both studies
shows strong expression in several brain regions, including the
somatosensory cortex and the thalamus (http://www.gensat.org/
creGeneView.jsp?founder_id64533&gene_id597) consistent
with our findings obtained with the Ai14 reporter mice. It is very
likely that the systemic administration of DTX-targeted GRP
neurons also at supraspinal sites, whereas the intrathecal injec-
tion of hyperbaric DTX solutions confined ablation to the spinal
cord (compare Fig. 3). Ablation of GRP neurons at several sites
might impact on the pain sensitivity of mice. First, the anterior
cingulate cortex and the insular cortex serve pivotal functions in
pain sensation and hyperalgesia. Second, the ventral posterior
thalamic nuclei are well-established relay stations of nociceptive
signals; and, finally, GRP neurons in the suprachiasmatic nucleus
of the hypothalamus serve pivotal functions in circadian biology
and sleep. Administration ofGRP at this site causes phase shifts in
circadian behavior (Piggins et al., 1995). Ablation of these neu-
rons may impair physiological sleep–wake cycles, which have re-
cently been shown to induce states of hyperalgesia (Alexandre et
al., 2017). Although the precise role in pain of theGRPneurons at
these sites remains to be defined, it cannot be excluded that their
ablation impairs pain responses.
A second potentially relevant difference between the two stud-
ies is the extent of GRP neuron activation. We have used local
AAV-mediated gene transfer to express hM3Dq in GRP neurons
Table 3. Supraspinal CNS regions anterogradely traced from lumbar spinal cord
GRP neuronsa
Brain area Region Stained cells
Cortical plate Agranular insular cortex (AI) 
Primary somatosensory cortex hindlimb region (S1HL) 
Cortical subplate Central nucleus of the amygdala (CeA) 
Pallidum Extended amygdala (EA) 
Hypothalamus Medial preoptic nucleus (MPO) 
Paraventricular hypothalamic nucleus posterior part (PaPo) 
Dorsomedial hypothalamic nucleus (DM) 
Lateral hypothalamic area (LHA) 
Thalamus Paraventricular thalamic nucleus anterior part (PVA) 
Paratenial thalamic nucleus (PT) 
Ventrolateral thalamic nucleus (VL) 
Paraventricular thalamic nucleus (PV) 
Mediodorsal thalamic nucleus medial part (MDM) 
Interanteromedial thalamic nucleus (IAM) 
Midline thalamic nuclei (MTN) 
Ventromedial thalamic nucleus (VM) 
Midbrain Red nucleus (R) 
Periaqueductal gray (PAG) 
Ventrolateral periaqueductal gray (VLPAG) 
Mesencephalic reticular formation (mRt) 
Median raphe nucleus (MRN) 
Isthmic reticular formation (isRT) 
Superior colliculus (SC) 
Dorsal raphe (DR) 
Pons Pontine nuclei (Pn) 
Locus coeruleus (LC) 
Medial parabrachial nucleus (MPB) 
Lateral parabrachial nucleus (LPB) 
Cerebellar nuclei Deep cerebellar nuclei (DCN) 
Lateral cerebellar nucleus (Lat) 
Medulla Intermediate reticular nucleus (iRt) 
Raphe magnus nucleus (RMg) 
Spinal vestibular nucleus (SpVe) 
Raphe obscurus nucleus (Rob) 
Lateral paragigantocellular nucleus (LPGi) 
aData are from 3mice., low density;, high density;, very high density.
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locally in three unilateral segments of the lumbar spinal cord.
Activationwas hence confined toGRPneurons of the dorsal horn
of only three lumbar segments of one side of the spinal cord (for
an illustration of the extent of AVV-mediated gene transfer, see
Foster et al., 2015). S. Sun et al. (2017) expressed the capsaicin
receptor TRPV1 globally in all GRP-positive cells and activated
GRP neurons via intrathecal capsaicin injection in a nonhyper-
baric solution. This procedure excites GRP neurons bilaterally
and likely over a large part of the spinal cord potentially extend-
ing even to the brainstem or brain. Finally, TRPV1 and hM3Dq
activate neurons via very different cellular signaling pathways
(i.e., either via direct gating of an ion channel or via activation of
a GPCR) and with different kinetics. It is conceivable that they
result in different firing patterns thatmay impact on downstream
release of fast or peptide neurotransmitters and on the decoding
of the postsynaptic signals, such as itch or pain.
Up to date, relatively little information is available about su-
praspinal CNS areas involved in the processing of pruritoceptive
signals. While brain imaging (fMRI) and PET studies in human
subjects have been instrumental in defining brain areas process-
ing sensory information in the visual, auditory, and nociceptive
system, their application in itch research is complicated by the
slow onset, and the waning and waxing nature of itch sensations
(Forster and Handwerker, 2014). Brain areas reported to be acti-
vated during exposure to different pruritic stimuli (or silenced
upon itch suppression) include prefrontal areas, insular cortex,
cingulate cortex, somatosensory cortex, thalamus, basal ganglia,
and cerebellum (Leknes et al., 2007; Papoiu et al., 2014, 2015; see
also Forster and Handwerker, 2014). Many of these areas were
also labeled in our virus-based anterograde tracing experiment
that started fromGRP neurons. These include the insular cortex,
sensory parts of the thalamus, the somatosensory cortex, the cer-
ebellum, the red nucleus, and the amygdala. Some differences
between the results of our tracing studies and previous imaging
experiments may be due to the specific incubation time of 4–5 d
after virus injection, whichmight have been too short to trace the
most rostral elements of the itch pathway, such as the anterior
cingulate cortex. On the other hand, our tracing study has iden-
tified specific labeling in certain deep brain structures and struc-
tures in the hindbrain that are difficult to detect with fMRI. These
include the paraventricular and dorsomedial hypothalamic nu-
clei, the ventrolateral periaqueductal gray, the locus ceruleus, the
raphe nuclei, and the parabrachial nucleus that has recently been
described as the first supraspinal relay site for itch signals (Mu et
al., 2017). Given the aversive nature of both itch and pain, it is not
surprising that brain regions activated in response to painful or
pruritic stimulation show big overlap (Forster and Handwerker,
2014; Vierow et al., 2015). In case of the herpes simplex-mediated
anterograde tracing, however, it needs to be considered that HSV
is propagated not only along excitatory pathways but also via
inhibitory connections, potentially leading to the labeling of
pathways that are suppressed by itch.
In conclusion, our results demonstrate that dorsal horn GRP
neurons constitute a rather homogeneous population of excit-
atory interneurons serving a critical role in the spinal relay of itch
signals. Our chemogenetic silencing experiments and diphtheria
toxin-mediated ablation of GRP neurons do not support a role of
these neurons in pain. The anatomical tracing experiments reveal
that the polysynaptic long-range projections that originate from
GRP neurons overlap with areas identified in functional brain
imaging experiments.
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